Clinical and Experimental Metastasis

Role of the tumor microenvironment in regulating the anti-metastatic effect of KISS1.  37:209-223. 2020

Automated quantitative image analysis for ex vivo metastasis assays reveals differing lung composition requirements for metastasis suppression by KISS1.  35:77-86. 2018

Perspective on the interpretation of research and translation to clinical care with therapy-associated metastatic breast cancer progression as an example.  34:443-447. 2017

Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer.  34:229-239. 2017

MTBP inhibits migration and metastasis of hepatocellular carcinoma.  32:301-311. 2015

Diet modulation is an effective complementary agent in preventing and treating breast cancer lung metastasis.  31:625-638. 2014

Nuclear localization of Kaiso promotes the poorly differentiated phenotype and EMT in infiltrating ductal carcinomas.  31:497-510. 2014

FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma.  30:555-568. 2013

L1CAM stimulates glioma cell motility and proliferation through the fibroblast growth factor receptor.  30:507-520. 2013

NM23 deficiency promotes metastasis in a UV radiation-induced mouse model of human melanoma.  30:25-36. 2013

CD44+/CD24- ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival.  29:939-948. 2012

Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis.  29:315-325. 2012

CD44+/CD24- ovarian cancer cells demonstrate cancer stem cell-like properties and correlate to survival..  28:400-406. 2012

Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ERα negative breast cancer cell lines.  28:437-449. 2011

Effect of zoledronic acid and amputation on bone invasion and lung metastasis of canine osteosarcoma in nude mice.  28:377-389. 2011

KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model.  27:591-600. 2010

Expression and functional analysis of the WAP four disulfide core domain 1 gene in human melanoma.  26:739-749. 2009

Multi-faceted role of HSP40 in cancer.  26:559-567. 2009

Nuclear magnetic resonance and circular dichroism study of metastin (Kisspeptin-54) structure in solution.  26:527-533. 2009

Dietary stearate reduces human breast cancer metastasis burden in athymic nude mice.  26:415-424. 2009

BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-κB binding site of the uPA promoter.  26:229-237. 2009

Multiple forms of BRMS1 are differentially expressed in the MCF10 isogenic breast cancer progression model.  26:89-96. 2009

Expressing connexin 43 in breast cancer cells reduces their metastasis to lungs.  25:893-901. 2008

Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer.  25:753-763. 2008

Syndecan-1: A dynamic regulator of the myeloma microenvironment.  25:149-159. 2008

Microarray analysis reveals potential mechanisms of BRMS1-mediated metastasis suppression.  24:551-565. 2007

Breast cancer metastasis to bone: Evaluation of bioluminescent imaging and microSPECT/CT for detecting bone metastasis in immunodeficient mice.  24:389-401. 2007

Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435.  23:123-133. 2006

A small molecule antagonist of the αυβ 3 integrin suppresses MDA-MB-435 skeletal metastasis.  21:119-128. 2004

Identification of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells.  21:149-157. 2004

A novel assay for the quantification of invasion from raft cultures of lung carcinomas.  21:1-6. 2004

Effects of α-difluoromethylornithine on local recurrence and pulmonary metastasis from MDA-MB-435 breast cancer xenografts in nude mice.  20:321-325. 2003

MDA-MB-435 human breast carcinoma metastasis to bone.  20:327-334. 2003

The skeleton as a unique environment for breast cancer cells.  20:275-284. 2003

Breast cancer metastasis suppressor 1: Update.  20:45-50. 2003

KISS1 metastasis suppression and emergent pathways.  20:11-18. 2003

Clinical & Experimental Metastasis: Introduction.  20:187. 2003

Clinical and Experimental Metastasis: Introduction.  20:1-2. 2003

B16F10 melanoma cell colonization of mouse lung is enhanced by partial pneumonectomy.  19:369-376. 2002

Influence of polyamines on in vitro and in vivo features of aggressive and metastatic behavior by human breast cancer cells.  19:95-105. 2002

Analysis of mechanisms underlying BRMS1 suppression of metastasis.  18:683-693. 2001

Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells.  18:391-400. 2000

The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines.  18:519-525. 2000

Metastasis-suppressed C8161 melanoma cells arrest in lung but fail to proliferate.  17:601-607. 1999

Calcitriol enhancement of TPA-induced tumorigenic transformation is mediated through vitamin D receptor-dependent and -independent pathways.  15:580-592. 1997

Suppression of human melanoma metastasis following introduction of chromosome 6 is independent of NME1 (Nm23).  15:259-265. 1997

Technical considerations for studying cancer metastasis in vivo.  15:272-306. 1997

Epidermal growth factor modulates cell attachment to hyaluronic acid by the cell surface glycoprotein CD44.  14:268-276. 1996

In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals.  13:407-419. 1995

U-77,863: a novel cinnanamide isolated from Streptomyces griseoluteus that inhibits cancer invasion and metastasis.  11:201-212. 1993

Tumor progression- and metastasis-associated proteins identified using a model of locally recurrent rat mammary adenocarcinomas.  8:533-551. 1990

A novel method for selection of invasive tumor cells: Derivation and characterization of highly metastatic K1735 melanoma cell lines based on in vitro and in vivo invasive capacity.  6:301-318. 1988

Implications of tumor progression on clinical oncology.  3:151-188. 1985

Chromosome and DNA analyses of rat 13762NF mammary adenocarcinoma cell lines and clones of different metastatic potentials.  2:271-286. 1984

Multiple phenotypic divergence of mammary adenocarcinoma cell clones - I. In vitro and in vivo properties.  2:333-355. 1984

Multiple phenotypic divergence of mammary adenocarcinoma cell clones. - II. Sensitivity to radiation, hyperthermia and FUdR.  2:357-371. 1984

Phenotypic drift and heterogeneity in response of metastatic mammary adenocarcinoma cell clones to Adriamycin, 5-fluoro-2′-deoxyuridine and methotrexate treatment in vitro.  1:317-325. 1983